Company intelligence / Profile preview

Nowarta Biopharma Inc.

Huntington Beach, California, United Statesnowarta.com ↗

Ownership: Private
Employees: ~10
Development stage: Phase 2

Overview

Successfully completed Phase I/II randomized double-blind clinical study for Nowarta110 with 64.3% efficacy versus 7.7% for placebo in treating plantar warts by week 6, with zero serious adverse events reported[2][3][9]

Therapeutic areas: Infectious Diseases
Modalities: Small molecule drugBotanical drug
Industry: Biotech

Drug pipeline

2 assets

Nowarta110

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Nowarta Biopharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nowarta Biopharma Inc..

Explore the full profile